Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
OpenUpdated: Oct 30, 2025
Summary
The purpose of this grant is to advance translational research on the emergence and trajectory of schizophrenia and related disorders in mid to late life, aiming to identify targets for future prevention and treatment efforts. Eligible applicants include for-profit organizations, government entities, nonprofits, educational institutions, and various other organizations, including those serving specific communities. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for further information.
Full Description
Description
Eligibility
Eligible applicants
Business
- For-profit organizations other than small businesses
- Small businesses
Government
- County governments
- Federally recognized Native American tribal governments
- City or township governments
- State governments
- Public and Indian housing authorities
- Special district governments
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.